Revolution Medicines, Inc. (RVMD)
152.49
-2.40
(-1.55%)
USD |
NASDAQ |
May 27, 15:43
Revolution Medicines EPS Diluted (Quarterly) : -2.291 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.317 |
| Erasca, Inc. | -0.6028 |
| Kodiak Sciences, Inc. | -0.9402 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Spyre Therapeutics, Inc. | -0.8785 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -453.82M |
| Total Expenses (Quarterly) | 453.82M |
| Enterprise Value | 31.46B |
| Earnings Yield | -4.64% |
| Normalized Earnings Yield | -4.560 |